Viewing Study NCT06770257


Ignite Creation Date: 2025-12-24 @ 7:02 PM
Ignite Modification Date: 2025-12-28 @ 1:06 AM
Study NCT ID: NCT06770257
Status: WITHDRAWN
Last Update Posted: 2025-06-03
First Post: 2025-01-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Daunorubicin, Cytarabine Liposomes Plus Venetoclax vs Azacitidine Plus Venetoclax in AML Patients Unfit for Intensive Chemotherapy
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module